Douglas B. Buchanan

Ainsworth Lumber Co. Ltd. was manufacturered and marketed oriented strand board with a focus on value-added specialty products for markets in North America and Asia. Its wood products included oriented strand board (OSB), oriented strand lumber (OSL) and specialty overlaid panels. The company's wholly-owned manufacturing facilities located in: Grande Prairie, Alberta; High Level, Alberta; 100 Mile House, British Columbia; and Barwick, Ontario. Ainsworth Lumber was founded on March 31, 1993 and was headquartered in Vancouver, Canada.

BC Biomedical Laboratories Ltd. provided diagnostic laboratory testing services. The company was headquartered in Surrey, Canada.

Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada.

Microbiome Insights, Inc. provides analysis and testing services for academic and industrial researchers. The firm’s services include experimental design consultation, sample extraction, nucleic acid processing and analysis as required (cdna generation, pcr, sequencing, etc.), basic data analysis, advanced data analysis, data and sample storage and submission to public databases. The company was founded by Malcolm C. Kendall, Barton B. Finlay and Bill Mohn in 2015 and is headquartered in Vancouver, Canada.

Abozymes Biomedical, Inc. develops biotechnology for blood transfusions and organ transplant services. The CEO of the Canadian company is John Coleman.